IRIS
MURINEDDU, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.323
AS - Asia 3.852
EU - Europa 2.268
SA - Sud America 2.208
AF - Africa 149
Continente sconosciuto - Info sul continente non disponibili 138
OC - Oceania 14
AN - Antartide 1
Totale 16.953
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.104
BR - Brasile 1.920
SG - Singapore 1.388
CN - Cina 1.194
UA - Ucraina 691
IT - Italia 511
VN - Vietnam 361
HK - Hong Kong 317
DE - Germania 292
FR - Francia 184
SE - Svezia 148
TR - Turchia 123
FI - Finlandia 120
AR - Argentina 115
GB - Regno Unito 102
BD - Bangladesh 77
CA - Canada 77
IN - India 72
IQ - Iraq 60
ZA - Sudafrica 45
MX - Messico 43
EC - Ecuador 41
RU - Federazione Russa 39
VE - Venezuela 36
UZ - Uzbekistan 34
CO - Colombia 33
BE - Belgio 31
MA - Marocco 31
JP - Giappone 27
ID - Indonesia 24
KE - Kenya 24
PK - Pakistan 24
KR - Corea 20
PL - Polonia 20
CR - Costa Rica 18
ES - Italia 18
CL - Cile 17
JO - Giordania 17
PY - Paraguay 17
TN - Tunisia 15
AT - Austria 13
AU - Australia 13
CZ - Repubblica Ceca 13
NL - Olanda 13
LT - Lituania 12
PE - Perù 12
RO - Romania 12
DO - Repubblica Dominicana 11
GT - Guatemala 11
JM - Giamaica 10
UY - Uruguay 10
AL - Albania 9
KZ - Kazakistan 9
OM - Oman 9
DZ - Algeria 8
EU - Europa 8
IR - Iran 8
NI - Nicaragua 8
NP - Nepal 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
HN - Honduras 7
IL - Israele 7
LB - Libano 7
BO - Bolivia 6
EG - Egitto 6
RS - Serbia 6
SA - Arabia Saudita 6
BH - Bahrain 5
KG - Kirghizistan 5
MY - Malesia 5
PS - Palestinian Territory 5
SN - Senegal 5
SV - El Salvador 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BG - Bulgaria 4
GP - Guadalupe 4
NG - Nigeria 4
PA - Panama 4
PH - Filippine 4
TH - Thailandia 4
BY - Bielorussia 3
CW - ???statistics.table.value.countryCode.CW??? 3
GE - Georgia 3
HU - Ungheria 3
KH - Cambogia 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AG - Antigua e Barbuda 2
AM - Armenia 2
BN - Brunei Darussalam 2
BS - Bahamas 2
DK - Danimarca 2
ET - Etiopia 2
IE - Irlanda 2
LV - Lettonia 2
MD - Moldavia 2
Totale 16.798
Salva come PNG Salva come JPEG
Città #
Dallas 2.772
Singapore 681
Chandler 675
San Jose 565
Ashburn 520
Jacksonville 422
Hong Kong 308
Council Bluffs 294
Beijing 247
Princeton 238
Dearborn 216
Santa Clara 199
Nanjing 192
Columbus 150
Ho Chi Minh City 134
New York 130
Lauterbourg 119
São Paulo 112
Ann Arbor 109
Wilmington 107
Milan 87
Hanoi 84
Shanghai 84
Los Angeles 80
Izmir 76
Rio de Janeiro 73
Washington 68
Sassari 67
Nanchang 57
Shenyang 56
Belo Horizonte 53
Woodbridge 46
Brasília 45
Rome 44
Hebei 43
Tianjin 42
Changsha 39
Baghdad 31
Jiaxing 31
Tashkent 31
Brussels 30
Guarulhos 27
Johannesburg 27
Tokyo 26
Miano 25
Porto Alegre 24
Boardman 23
Curitiba 23
Houston 23
Toronto 23
Buffalo 22
Kunming 22
Nairobi 22
Denver 21
Helsinki 21
Montreal 21
San Francisco 20
Santo André 20
Andover 19
Buenos Aires 19
Ningbo 19
Orem 19
Seoul 19
Campinas 18
Caxias do Sul 18
Guangzhou 18
Jinan 18
Norwalk 18
Sorocaba 18
Amman 17
Ribeirão Preto 17
San Mateo 17
Warsaw 17
Da Nang 16
Frankfurt am Main 16
Hangzhou 16
Istanbul 16
Mountain View 16
Munich 16
The Dalles 16
Brooklyn 15
Guayaquil 15
Quito 15
San José 15
Bogotá 14
Chicago 14
Haiphong 14
London 14
Contagem 13
Dhaka 13
Fortaleza 13
Goiânia 13
Salvador 13
Zhengzhou 13
Asunción 12
Cagliari 12
Casablanca 12
Manaus 12
Mumbai 12
Osasco 12
Totale 10.396
Salva come PNG Salva come JPEG
Nome #
Synthesis of Novel Tricyclic N-Acylhydrazones as Tubulin Polymerization Inhibitors 479
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity 301
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 266
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 258
Design and synthesis of novel FGFR inhibitors for the treatment of glioblastoma 254
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and biological evaluation 227
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 201
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6- tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. 195
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers 194
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 180
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 175
Composti farmaceutici 173
Approcci terapeutici contro il cancro. Tradizione e innovazione. 170
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands 166
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 166
Antiviral activity of benzotriazole based derivatives 165
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 163
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 163
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 160
3-(5-Phenyl[1,3,4]oxadiazol-2-yl)-1H-benzo]g]indole and related compounds: synthesis and cytotoxic acitivities 158
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 155
Oxadiazoles having antiproliferative activity 154
Chiral pyridine N-oxides useful ligands for asymmetric catalysis 152
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 152
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 151
CAPITOLO 41. Antielmintici 151
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues 150
A survey of Recent Patents on CB2 Agonists in the Management of Pain 150
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors 149
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 149
The organic chemistry of drug design and drug action 147
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 147
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 145
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 143
Pharmaceutical compounds 142
Chimica farmaceutica 142
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 141
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 140
Chromophore-modified bis-benzo[g]indolecarboxamides: synthesis and citotoxicity of bis-benzo[g]indazole-3-carboxamides and related compounds 140
Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors 139
Tricyclic pyrazoles. Part 3. Synthesis, biological evaluation and molecular modelling of analogues of the cannabinoid antagonist NESS 0327 138
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 138
An overview on different classes of viral entry and respiratory syncitial virus (RSV) fusion inhibitors 134
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as μ-opioid receptor agonists. Effects on μ-affinity of arylalkenyl chain modifications 132
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 131
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 131
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 131
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 129
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines 127
Pharmaceutical Compounds 127
Diazacyclic compounds having affinity for opioid receptors 126
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors 126
Synthesis and cytotoxicity evaluation of thiophene analogues of 1-methyl-2,3-bis(hydroxymethyl)benzo[g]indole bis[N-(2-propyl)carbamate] 124
Pharmaceutical Compounds 124
Oxadiazoles having anti proliferative activity 124
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 124
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides 123
Synthesis of biologically active bridged diazabicycloheptanes 123
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 123
Pharmaceutical compounds 122
Design of a new class of chiral C2-symmetric dipyridylmethane ligands and their application in asymmetric catalysis 122
Development and characterization of novel cannabinoid derivatives based on diarylpyridazine scaffold. 122
Synthesis and cytotoxicity of substituted 2-benzylnaphth[2,3-d]imidazoles 121
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2 ',4 '-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyra zole-3-carboxamide 119
I farmaci antivirali. Dalla progettazione all’impiego terapeutico. 118
Novel diazabicycloalkane delta opioid agonists 118
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety 118
Synthesis, modelling, and m-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes 116
Ring-fused pyrazole derivates as ligands for cannabinoid receptors: synthesis and investigation of structure-activity relationships 115
Chimica farmaceutica. Con e-book 115
Pharmaceutical compounds 114
Pharmaceutical compounds 114
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzolglindazole-based ligands for cannabinoid receptors 114
Synthesis and application in asymmetric copper(I)-catalyzed allylic oxidation of a new chiral 1,10-phenantroline derived from pinene 113
Pirazoli triciclici: sintesi e valutazione biologica di ligandi per i recettori cannabinoidei con struttura diidroindenopirazolica contenenti differenti sostituenti carbossammidici 113
Sintesi di 1,10-fenantroline chirali a simmetria C2 derivati da monoterpeni naturali quali utili leganti per la catalisi asimmetrica 113
Pharmaceutical compounds 113
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and antileukemia evaluation 112
Manuale di chimica farmaceutica. Progettazione, meccanismo d'azione e metabolismo dei farmaci 111
Synthesis and biological evaluation of diazabiciclo[3.3.1]nonanes with a thiother bridge 111
Synthesis of chiral C2-symmetric 1,10-phenanthrolines from naturally occurring monoterpenes 110
Pharmaceutical compounds 110
Synthesis and tumor cell lines inhibition of 1,3,4.oxadiazoles linked to tricyclic pyrroles 108
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors 107
Pharmaceutical compounds 106
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors 105
Ossadiazoli ad attività antiproliferativa 105
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes 105
I 3,6-diazabiciclo[3.1.1]eptani: una nuova serie di potenti agonisti per i recettori µ degli oppioidi 105
Pyrazolo-naphthyridines: Design and Synthesis of potential CB-ligands 104
Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties 102
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives 101
Synthesis, Pharmacological Evaluation and Docking Studies of Pyrrole Structure-Based CB2 Receptor Antagonists 101
Different classes of CB2 Ligands Potentially Useful in the Treatment of Pain. 100
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazoles: A versatile architecture for CB2 selective ligands 100
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors 100
Synthesis and biological evaluation of novel CB2 ligands 100
Substituted 3,8-diazabicyclo[3.2.1]octane compounds 99
Principi generali. In: Chimica Tossicologica 99
Synthesis, pharmacological evaluation and docking studies of pirrole structure-based CB2 receptor antagonists. 98
Totale 14.087
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.892
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022490 0 0 0 7 8 5 28 48 51 37 61 245
2022/20231.271 130 78 27 229 110 210 2 161 228 8 56 32
2023/2024396 58 26 15 7 37 81 1 55 3 4 50 59
2024/20253.579 20 20 186 59 124 117 277 583 1.351 573 161 108
2025/20266.509 222 1.544 1.679 875 387 312 669 146 248 245 144 38
2026/20271.737 150 402 467 718 0 0 0 0 0 0 0 0
Totale 16.953